Download PDF
Thromb Haemost 1973; 29(03): 547-561
DOI: 10.1055/s-0038-1647796
Original Article
Schattauer GmbH

Congenital Dysfibrinogenemmia(Fibrinogen Giessen)[*]

W.H Krause
1   Department of Medicine, University of Giessen, Germany
,
D.L Heene
1   Department of Medicine, University of Giessen, Germany
,
H.G Lasch
1   Department of Medicine, University of Giessen, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
30 June 2018 (online)

Also available at
    Permissions and Reprints

Summary

This report discusses congenital dysfibrinogenemia with facultative hemorrhagic diathesis in a 27-year-old woman patient. The autosomal-dominant hereditary transmission is assumed because of the occurrence of dysfibrinogenemia in the patient’s daughter now two-years-old. More extensive genetic examinations were impossible as the patient had been adopted.

The thrombin-time, the thromboplastin- and the partial thromboplastin-time were all prolonged. Reptilase and arvin did not lead to visible coagulation. Immunologically the concentration of fibrinogen was found to be normal, but fibrinogen, when determined as a thrombin clottable protein was clearly reduced. The patient’s plasma and isolated fibrinogen had an inhibitory effect on the coagulation of normal plasma or fibrinogen. Inhibitory factors of the fibrinogen-fibrin transition or an increased fibrinolysis was not found. An isolated determination of coagulation factors gave normal results. The fibrin polymerisation of the patient’s isolated fibrin monomer was delayed and did not reach the normal maximum. By applying bidimen- sional paper electrophoresis to the patient’s isolated fibrinogen after incubation with thrombin the separation of fibrinopeptide A was shown to be absent. Plasmin applied to the pathological fibrinogen did not release any late lysis products. Based on these findings which in part differ from other reported anomalies of fibrinogen, we propose to call this variant type of fibrinogen Giessen.

* This work was presented in part at the III Congress of the International Society on Thrombosis and Haemostasis, Washington, D.C. August 22-26, 1972.


 

  • References

  • 1 Abildgaard U. 1966; Acceleration of fibrin polymerization by dextran and ficoll. Interaction with calcium and plasma proteins. Scandinavian Journal of Clinical and Laboratory Investigation 18: 518.
    PubMedSearch in Google Scholar
  • 2 Astrup T, Barkman P, Nissen U. 1965; The estimation of fibrinogen. Scandinavian Journal of Clinical and Laboratory Investigation 17: 57.
    CrossrefPubMedSearch in Google Scholar
  • 3 Bachmann F, Duckert F, Koller F. 1958; The Stuart-Prower Factor assay and its clinical significance. Thrombosis et Diathesis Haemorrhagica 02: 24.
    PubMedSearch in Google Scholar
  • 4 Beck E. A. 1964; Abnormal fibrinogen (fibrinogen Baltimore) as a cause of familial hemorrhagic disorder. Blood 24: 853.
    PubMedSearch in Google Scholar
  • 5 Beck E. A, Mosesson M. W, Charache P, Jackson D. P. 1966; Hämorrhagische Diathese mit dominantem Erbgang, verursacht durch ein anomales Fibrinogen (Fibrinogen Baltimore). Schweizer medizinische Wochenschrift 96: 1196.
    PubMedSearch in Google Scholar
  • 6 Beck E. A, Shainoff J. R, Vogel A, Jackson D. P. 1971; Functional evaluation of an inherited abnormal fibrinogen. The Journal of Clinical Investigation 50: 1874.
    CrossrefPubMedSearch in Google Scholar
  • 7 Belitser Y. A, Varetskaja T. Y, Malneva G. Y. 1968; Fibrinogen-fibrin interaction. Biochimica et Biophysica Acta 154: 367.
    CrossrefPubMedSearch in Google Scholar
  • 8 Biggs R, MacFarlane R. G. 1962. Human Blood Coagulation and its Disorders. Blackwell Scientific Publication. Oxford.:
    Search in Google Scholar
  • 9 Blombäck M, Blombäck B, Mammen E. F. Prasad 1968; Fibrinogen Detroit - a Molecular Defect in the IST-terminal Disulfide Knot of Human Fibrinogen. Nature 218: 134.
    CrossrefPubMedSearch in Google Scholar
  • 10 Blombäck B, Blombäck M. 1970; Molecular Defects and Variants of Fibrinogen. Nouvelle Française d’Hématologie 10: 671.
    PubMedSearch in Google Scholar
  • 11 Duke W. W. 1910; The relation of blood platelets to hemorrhagic disease. Journal of the American Medical Association 55: 1185.
    CrossrefPubMedSearch in Google Scholar
  • 12 Feissly R, Lttdin H. 1949; Microscopic par contrastes de phase. Revue d’hématologie 04: 481.
    PubMedSearch in Google Scholar
  • 13 Von Felten A, Duckest F, Frick P. G. 1965; Gerinnungsstörung ohne hämorrhagische Diathese infolge verzögerter Aggregation der Fibrinmoleküle. Schweizerische Medizinische Wochenschrift 95: 1965.
    PubMedSearch in Google Scholar
  • 14 Von Felten A, Frick P. G, Straub P. W. 1969; Studies on fibrin monomer aggregation in congenital dysfibrinogenaemia (Fibrinogen Zürich) : Separation of a pathological from a normal fibrin fraction. British Journal of Haematology 16: 353.
    CrossrefPubMedSearch in Google Scholar
  • 15 Forman W. B, Ratnoef O. D, Boyer M. H. 1968; An inherited qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland. J ournal of Laboratory and Clinical Medicine 72: 455.
    PubMedSearch in Google Scholar
  • 16 Funk C, Straub P. W. 1970; Hereditary abnormality of fibrin monomer aggregation (Fibrinogen Zürich II). European Journal of Clinical Investigation 01: 131.
    PubMedSearch in Google Scholar
  • 17 Gralnick H. R, Givelber H. Finlayson 1970; A familial bleeding disorder associated with dysfibrinogenemia. Clinical Research 18: 405.
    PubMedSearch in Google Scholar
  • 18 Gralnick H. R, Givelber H. M, Shainoef J. R, Finlayson J. S. 1971; Fibrinogen Bethesda : a congenital dy sfibrino genemia with delayed fibrinopeptide release. J ournal of Clinical Investigation 50: 1819.
    PubMedSearch in Google Scholar
  • 19 Gralnick H. R, Givelber H. M, Finlayson J. S. 1972 Congenital dysfibrinogenemia. fibrinogen Bethesda II..
    PubMedSearch in Google Scholar
  • 20 Gralnick H. R, Givelber H. M, Finlayson J. S. 1973; A new congenital abnormality of human Fibrinogen: Fibrinogen Bethesda II. Thrombosis et Diathesis Haemorrhagica 29: 562.
    PubMedSearch in Google Scholar
  • 21 Hampton J. W. 1968; Qualitative fibrinogen defect associated with abnormal fibrin stabilization. Journal of Laboratory and Clinical Medicine 72: 882.
    PubMedSearch in Google Scholar
  • 22 Hampton J. W, Morton R. O. 1970; Fibrinogen Oklahoma - Recharacterization of a Familial bleeding diathesis. XIII. International Congress of Hematology Munich August 2-8th, Abstract, 313.
    PubMedSearch in Google Scholar
  • 23 Hardisty R. M, McPherson J. C. 1962; A one-stage factor VIII (antihaemophilic globulin) assay, its use on venous and capillary plasma. Thrombosis et Diathesis Haemorrhagica 07: 215.
    PubMedSearch in Google Scholar
  • 24 Hasselback R, Marion B, Thomas J. W. 1963; Congenital hypofibrinogenemia in five members of a family. Canadian Medical Association Journal 88: 19.
    PubMedSearch in Google Scholar
  • 25 Heene D. 1968; Bestimmungsmethoden von F XIII. In: Deutsch, E., Fischer, M. and Le ohne R K 28: 33.
    PubMedSearch in Google Scholar
  • 26 Heinrich D, Röka L. 1970; Methode zur Bestimmung der Thrombozytenaggregation. Klinische Wochenschrift 48: 235.
    CrossrefPubMedSearch in Google Scholar
  • 27 Imperato D. C, Dettori A. G. 1958; Ipofibrinogenemia congenita con fibroastenia. Helvetia Paediatrica Acta 13: 380.
    PubMedSearch in Google Scholar
  • 28 Janssen G. L, Vreeken J. 1971; Fibrinogen Amsterdam, another hereditary abnormality of fibrinogen. British J ournal of Haematology 20: 287.
    PubMedSearch in Google Scholar
  • 29 Jürgens J, Beller F. K. 1959. Klinische Methoden der Blutgerinnungsanalysen. Thieme Verlag. Stuttgart: 279.
    Search in Google Scholar
  • 30 Kazal L. A, Amsel S, Miller O. P, Tokantins L. M. 1963; The preparation and some properties of fibrinogen precipitated from human plasma by glycine. Proceedings of the Society for Experimental Biology and Medicine (N. Y.) 113: 989.
    PubMedSearch in Google Scholar
  • 31 Kesseler K. 1959; Über die klinische Bedeutung des Thrombin-Bildungstests. Deutsche Medizinische Wochenschrift 84: 267.
    Thieme ConnectPubMedSearch in Google Scholar
  • 32 Koller F, Loeliger A, Duckert F. 1951; Experiments on a new clotting Factor (Factor VII). Acta haematologica 06: 1.
    CrossrefPubMedSearch in Google Scholar
  • 33 Krause W, Heeke D, Lasch H. G. 1971; Ein neuer Fall von Dysfibrinogenaemie. Klinische Wochenschrift 49: 806.
    CrossrefPubMedSearch in Google Scholar
  • 34 Krause W, Zimmermann P. 1972; Quantitative elektronenmikroskopische Untersuchungen zur Fibrinstruktur bei Dysfibrinogenämie. Klinische Wochenschrift 50: 557.
    CrossrefPubMedSearch in Google Scholar
  • 35 Krause W. H, Bleyl H. 1973; Investigation on plasminproteolysis of abnormal fibrinogen. Thrombosis Research 02: 361.
    CrossrefPubMedSearch in Google Scholar
  • 36 Latallo Z. S, Fletscher A. P, Alkjaersig N, Sherry S. 1962; The influence of pH, ionic strength, neutral ions and thrombin on the fibrin polymerization. American Journal of Physiology 202: 675.
    PubMedSearch in Google Scholar
  • 37 Lacombe M, Soria J, Soria C, D’Angelo G, Lavallée R, Bonny Y. 1972. A new case of congenital dysfibrinogenemia without bleeding tendency. The fibrinogen “Montreal”. Ill Congress of the International Society on Thrombosis and Haemostasis. Washington D. C; August 22-26th (abstract) 114.
    Search in Google Scholar
  • 38 Lacombe M, Soria J, Soria C, D’Angelo G, Lavellée R, Bonny Y. 1973; Fibrinogen Montreal. A new case of congenital dysfibrinogenemia with defective aggregation of monomers. Thrombosis et Diathesis Haemorrhagica 29: 536.
    PubMedSearch in Google Scholar
  • 39 Mammen E. F, Prasad A. S. 1968; Familiäre Dysfibrinogenämie - “Fibrinogen Detroit”, Verhandlungen der Deutschen Gesellschaft für innere Medizin. 74: 140.
    PubMedSearch in Google Scholar
  • 40 Mammen E. F, Prasad A. S, Barnhardt M. J, Au C. C. 1969; Congenital Dysfibrinogenemia: Fibrinogen Detroit. Journal of Clinical Investigation 48: 235.
    CrossrefPubMedSearch in Google Scholar
  • 41 Mancini G, Carbonara A. O, Heremans J. 1965; Immunochemical quantitation of antigens by single radial immunodiffusion. Immuno chemistry 02: 235.
    PubMedSearch in Google Scholar
  • 42 Martinez J, Holburn R. R, Shapiro S. S, Erslev A. J. 1972; Hereditary hypo- dysfibrinogenemia characterized by fibrinogen hyper catabolism. Journal of Clinical Investigation 551: 62a (abstract)
    PubMedSearch in Google Scholar
  • 43 Ménaché D. 1963; Dysfibrinogénémia constitutionelle et familiale. Proceedings of the ninth Congress of European Society of Haematology II 02: 1255.
    PubMedSearch in Google Scholar
  • 44 Ménaché D. 1964; Constitutional and familial abnormal fibrinogen. Thrombosis et Diathesis haemorrhagica, Supplementum 13: 173.
    PubMedSearch in Google Scholar
  • 45 Michaelis L. 1931; Der Acetat-Veronal Puffer. Biochemische Zeitschrift 234: 139.
    PubMedSearch in Google Scholar
  • 46 Milstone H. 1941; A factor in normal human blood which participates in streptococcal fibrinolysis. Journal of Immunology 42: 1086.
    PubMedSearch in Google Scholar
  • 47 Mosesson M. W, Beck E. A. 1969; Chromatographic, ultracentrifugal and related studies of fibrinogen “Baltimore”. Journal of Clinical Investigation 48: 1656.
    CrossrefPubMedSearch in Google Scholar
  • 48 Mosesson M. W, Finlayson J. S. 1963; Heterogenity of human fibrinogen. Biochemistry 02: 42.
    CrossrefPubMedSearch in Google Scholar
  • 49 Müller-Berghaus G, Röka L, Lasch H. G. 1971; Fibrinmonomer und das Sanarelli- Shwartzman-Phänomen. Verhandlungen der Deutschen Gesellschaft für innere Medizin 77: 161.
    PubMedSearch in Google Scholar
  • 50 Müller-Berghaus G, Heinrich D. 1972; Fibrinmonomer and platelet aggregation in vitro and in vivo. British Journal of Haematology 23: 177.
    PubMedSearch in Google Scholar
  • 51 Owen j.r, Ch A, Bowie E. J. W, Didisheim P, Thompson Jr J. H.. 1969. The Diagnosis of Bleeding Disorders. J. & A; Churchill Ltd., London.:
    Search in Google Scholar
  • 52 Proctor R. R, Rapaport S. I. 1961; The partial thromboplastin time with kaolin. American Journal of Clinical Pathology 36: 212.
    CrossrefPubMedSearch in Google Scholar
  • 53 Quick A. J. 1945; On the quantitative estimation of prothrombin. American Journal of Clinical Pathology 15: 560.
    CrossrefPubMedSearch in Google Scholar
  • 54 Ratnoff O. D, Busse R. J, Sheon R. P. 1968; The Demise of John Hageman. The New England Journal of Medicine 297: 760.
    PubMedSearch in Google Scholar
  • 55 Samama M, Soria J, Soria C, Bousser J. 1969; Dysfibrinogénémie congénitaile et familiale sans tendance hémorrhagique. Nouvelle Revue Française d’Hematologie 09: 817.
    PubMedSearch in Google Scholar
  • 56 Scheidegger J. J. 1955; Une microméthode de l’immunoélectrophorése. International Archives of Allergy and Applied Immunology 07: 103.
    CrossrefPubMedSearch in Google Scholar
  • 57 Schmutzler R, Wenzel M, Heimburger I. S.T. 1972. Determination of plasminogen - proactivator (PP). Ill Congress of the International Society on Thrombosis and Haemostasis. Washington D. C; August 22-26th (abstract) 306.
    Search in Google Scholar
  • 58 Schwick H. G, Störiko K. 1966; Die Bestimmung von Inhibitoren der Blutgerinnung. »Laboratoriumsblätter« Behring - Werke 01: 72.
    PubMedSearch in Google Scholar
  • 59 Sherman L. A, Gaston L. W, Spivack A. R. 1968; Studies on a patient with a fibrinogen variant and hemophilia A. Journal of Laboratory and Clinical Medicine 72: 1017.
    PubMedSearch in Google Scholar
  • 60 Sherman L. A, Gaston L. W, Kaplan M, Spivack A. R. 1972; Fibrinogen St. Louis : A new inherited fibrinogen variant, coincidentally associated with hemophilia A. Journal of Clinical Investigation 51: 590.
    PubMedSearch in Google Scholar
  • 61 Soria J, Samama M, Soria C, Conrad J, Kling C, Poirot E, Bottsser J. 1971. Two new cases of congenital dysfibrinogenemia. II. Congress of the International Society on Thrombosis and Haemostasis. Oslo; July 12-16th, 58.
    Search in Google Scholar
  • 62 Soria J, Soria C, Samama M, Poirot E, Kling C. 1972; Fibrinogen Troyes - Fibrinogen Metz. Two New Cases of Congenital Dy sfibrinogenemia. Thrombosis et Diathesis haemor- rhagica 27: 619.
    PubMedSearch in Google Scholar
  • 63 Stocker K, Straub P. W. 1970; Rapid detection of fibrinopeptides by bidimensional paper electrophoresis. Thrombosis et Diathesis Haemorrhagica 24: 248.
    PubMedSearch in Google Scholar
  • 64 Streiff F, Alexandre P, Vigneron G, Soria J, Soria C, Mester L. 1971; Un nouveau cas d’anomalie constitutioneile et familiale du fibrinogène sans diathese hémorragique. Thrombosis et Diathesis Haemorrhagica 26: 565.
    PubMedSearch in Google Scholar
  • 65 Thaler E, Lechner K, Deutsch E. 1973. Fibrinogen Wien. Verhandlungen der Deutschen Arbeitsgemeinschaft für Blutgerinnungsforschung. 14. Tagung in Münster 15—17. Februar. F.K; Schattauer Verlag, Stuttgart: (im Druck)
    Search in Google Scholar
  • 66 Vermylen C, de Vreker R. A, Verstraete M. 1963; A rapid enzymatic method for assay of fibrinogen fibrin polymerization time. Clinica chimica Acta 08: 418.
    CrossrefPubMedSearch in Google Scholar
  • 67 Verstraete M. 1970; A new fibrinogen anomaly. Thrombosis et Diathesis Haemorrhagica, Supplementum 39: 334.
    PubMedSearch in Google Scholar
  • 68 Walker L, Catlin A. 1971; A simplified method for preparation of fibrinogen. Thrombosis et Diathesis Haemorrhagica 26: 99.
    PubMedSearch in Google Scholar
  • 69 Winckelmann G, Augustin R, Bandilla K. 1971. Report of a new family (Fibrinogen Wiesbaden). II. Congress of the International Society on Thrombosis and Haemostasis. Oslo; July 12-16th, 64.
    Search in Google Scholar
  • 70 Winckelmann G. 1972. Kongenitale Dysfibrinogenämie : Bericht über eine neue Familie. Verhandlungen der Deutschen Arbeitsgemeinschaft für Blutgerinnungsforschung. 13. Tagung in Bonn 17.-19. Februar. F. K; Schattauer Verlag, Stuttgart: (im Druck)
    Search in Google Scholar
  • 71 Zietz B. H, Scott J. L. 1970; An inherited defect in fibrinogen polymerization : Fibrinogen Los Angeles. Clinical Research (N. Y.) 18: 179.
    PubMedSearch in Google Scholar